|
1
|
World Health Organization, . Mercury and
health. Fact sheet. 2016.http://www.who.int/mediacentre/factsheets/fs361/en/Updated
March 2017.
|
|
2
|
Salonen JT, Seppänen K, Nyyssönen K,
Korpela H, Kauhanen J, Kantola M, Tuomilehto J, Esterbauer H,
Tatzber F and Salonen R: Intake of mercury from fish, lipid
peroxidation, and the risk of myocardial infarction and coronary,
cardiovascular, and any death in eastern Finnish men. Circulation.
91:645–655. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Clarkson TW, Magos L and Myers GJ: The
toxicology of mercury-current exposures and clinical
manifestations. N Engl J Med. 349:1731–1737. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Houston MC: Role of mercury toxicity in
hypertension, cardiovascular disease, and stroke. J Clin Hypertens
(Greenwich). 13:621–627. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mutter J, Naumann J, Sadaghiani C,
Schneider R and Walach H: Alzheimer disease: Mercury as
pathogenetic factor and apolipoprotein E as a moderator. Neuro
Endocrinol Lett. 25:331–339. 2004.PubMed/NCBI
|
|
6
|
Fernandes Azevedo B, Barros Furieri L,
Peçanha FM, Wiggers GA, Frizera Vassallo P, Ronacher Simões M,
Fiorim J, de Batista Rossi P, Fioresi M, Rossoni L, et al: Toxic
effects of mercury on the cardiovascular and central nervous
systems. J Biomed Biotechnol. 2012:9490482012.PubMed/NCBI
|
|
7
|
Furieri LB, Galán M, Avendaño MS,
García-Redondo AB, Aguado A, Martínez S, Cachofeiro V, Bartolomé
MV, Alonso MJ, Vassallo DV and Salaices M: Endothelial dysfunction
of rat coronary arteries after exposure to low concentrations of
mercury is dependent on reactive oxygen species. Br J Pharmacol.
162:1819–1831. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pecanha FM, Wiggers GA, Briones AM,
Perez-Giron JV, Miguel M, Garcia-Redondo AB, Vassallo DV, Alonso MJ
and Salaices M: The role of cyclooxygenase (COX)-2 derived
prostanoids on vasoconstrictor responses to phenylephrine is
increased by exposure to low mercury concentration. J Physiol
Pharmacol. 61:29–36. 2010.PubMed/NCBI
|
|
9
|
Rizzetti DA, Torres JG, Escobar AG,
Peçanha FM, Santos FW, Puntel RL, Alonso MJ, Briones AM, Salaices
M, Vassallo DV and Wiggers GA: Apocynin prevents vascular effects
caused by chronic exposure to low concentrations of mercury. PLoS
One. 8:e558062013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wiggers GA, Peçanha FM, Briones AM,
Pérez-Girón JV, Miguel M, Vassallo DV, Cachofeiro V, Alonso MJ and
Salaices M: Low mercury concentrations cause oxidative stress and
endothelial dysfunction in conductance and resistance arteries. Am
J Physiol Heart Circ Physiol. 295:H1033–H1043. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wiggers GA, Stefanon I, Padilha AS,
Pecanha FM, Vassallo DV and Oliveira EM: Low nanomolar
concentration of mercury chloride increases vascular reactivity to
phenylephrine and local angiotensin production in rats. Comp
Biochem Physiol C Toxicol Pharmacol. 147:252–260. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rice DC: The US EPA reference dose for
methylmercury: Sources of uncertainty. Environ Res. 95:406–413.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cheah IK and Halliwell B: Ergothioneine;
antioxidant potential, physiological function and role in disease.
Biochim Biophys Acta. 1822:784–793. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Melville DB, Horner WH and Lubschez R:
Tissue ergothioneine. J Biol Chem. 206:221–228. 1954.PubMed/NCBI
|
|
15
|
Shires TK, Brummel MC, Pulido JS and
Stegink LD: Ergothioneine distribution in bovine and porcine ocular
tissues. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol.
117:117–120. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shukla Y, Kulshrestha OP and Khuteta KP:
Ergothioneine content in normal and senile human cataractous
lenses. Indian J Med Res. 73:472–473. 1981.PubMed/NCBI
|
|
17
|
Gründemann D, Harlfinger S, Golz S, Geerts
A, Lazar A, Berkels R, Jung N, Rubbert A and Schömig E: Discovery
of the ergothioneine transporter. Proc Natl Acad Sci USA.
102:5256–5261. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Melville DB: Ergothioneine. Vitamin Horm.
17:155–204. 1959. View Article : Google Scholar
|
|
19
|
Paul BD and Snyder SH: The unusual amino
acid L-ergothioneine is a physiologic cytoprotectant. Cell Death
Differ. 17:1134–1140. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Motohashi N and Mori I: The role of
ergothioneine in the oxidation of reduced nicotinamide adenine
dinucleotide by metmyoglobin or methemoglobin. Chem Pharm Bull
(Tokyo). 31:1702–1707. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Reglinski J, Smith WE and Sturrock RD:
Spin-echo 1H NMR detected response of ergothioneine to oxidative
stress in the intact human erythrocyte. Magn Reson Med. 6:217–223.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hartman PE: Ergothioneine as antioxidant.
Methods Enzymol. 186:310–318. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Akanmu D, Cecchini R, Aruoma OI and
Halliwell B: The antioxidant action of ergothioneine. Arch Biochem
Biophys. 288:10–16. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aruoma OI, Whiteman M, England TG and
Halliwell B: Antioxidant action of ergothioneine: Assessment of its
ability to scavenge peroxynitrite. Biochem Biophys Res Commun.
231:389–391. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mitsuyama H and May JM: Uptake and
antioxidant effects of ergothioneine in human erythrocytes. Clin
Sci (Lond). 97:407–411. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Franzoni F, Colognato R, Galetta F,
Laurenza I, Barsotti M, Di Stefano R, Bocchetti R, Regoli F, Carpi
A, Balbarini A, et al: An in vitro study on the free radical
scavenging capacity of ergothioneine: comparison with reduced
glutathione, uric acid and trolox. Biomed Pharmacother. 60:453–457.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gokce G and Arun MZ: Ergothioneine
produces relaxation in isolated rat aorta by inactivating
superoxide anion. Eur Rev Med Pharmacol Sci. 18:3339–3345.
2014.PubMed/NCBI
|
|
28
|
Sit ASM, Ho EYW, Li RWS, et al:
Ergothioneine shows protective effect on endothelial cells in
oxidative stress. Faseb J. 25:630–633. 2011.
|
|
29
|
Martin KR: The bioactive agent
ergothioneine, a key component of dietary mushrooms, inhibits
monocyte binding to endothelial cells characteristic of early
cardiovascular disease. J Med Food. 13:1340–1346. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li RW, Yang C, Sit AS, Kwan YW, Lee SM,
Hoi MP, Chan SW, Hausman M, Vanhoutte PM and Leung GP: Uptake and
protective effects of ergothioneine in human endothelial cells. J
Pharmacol Exp Ther. 350:691–700. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang HD, Xu S, Johns DG, Du Y, Quinn MT,
Cayatte AJ and Cohen RA: Role of NADPH oxidase in the vascular
hypertrophic and oxidative stress response to angiotensin II in
mice. Circ Res. 88:947–953. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lowry OH, Rosebrough NJ, Farr Al and
Randall RJ: Protein measurement with the Folin phenol reagent. J
Biol Chem. 193:265–275. 1951.PubMed/NCBI
|
|
33
|
Majithiya JB, Paramar AN and Balaraman R:
Pioglitazone, a PPARgamma agonist, restores endothelial function in
aorta of streptozotocin-induced diabetic rats. Cardiovasc Res.
66:150–161. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gomez Garcia M, Boffetta P, Klink
Caballero JD, Espanol S and Quintana Gomez J: Cardiovascular
mortality in mercury miners. Med Clin (Barc). 128:766–771. 2007.(In
Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gokce N, Keaney JF Jr, Hunter LM, Watkins
MT, Nedeljkovic ZS, Menzoian JO and Vita JA: Predictive value of
noninvasively determined endothelial dysfunction for long-term
cardiovascular events in patients with peripheral vascular disease.
J Am Coll Cardiol. 41:1769–1775. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Widlansky ME, Gokce N, Keaney JF Jr and
Vita JA: The clinical implications of endothelial dysfunction. J Am
Coll Cardiol. 42:1149–1160. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Massaroni L, Rossoni LV, Amaral SM,
Stefanon I, Oliveira EM and Vassallo DV: Haemodynamic and
electrophysiological acute toxic effects of mercury in
anaesthetized rats and in langendorff perfused rat hearts.
Pharmacol Res. 32:27–36. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Guzik TJ and Channon KM: Measurement of
vascular reactive oxygen species production by chemiluminescence.
Methods Mol Med. 108:73–89. 2005.PubMed/NCBI
|
|
39
|
Pacher P, Beckman JS and Liaudet L: Nitric
oxide and peroxynitrite in health and disease. Physiol Rev.
87:315–424. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Katusic ZS and Vanhoutte PM: Superoxide
anion is an endothelium-derived contracting factor. Am J Physiol.
257:H33–H37. 1989.PubMed/NCBI
|
|
41
|
Vanhoutte PM: Endothelium-derived free
radicals: For worse and for better. J Clin Invest. 107:23–25. 2001.
View Article : Google Scholar : PubMed/NCBI
|
